Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioventus Inc.

6.77
+0.11001.65%
Post-market: 6.770.00000.00%17:54 EDT
Volume:2.03M
Turnover:13.76M
Market Cap:449.24M
PE:-14.11
High:6.86
Open:6.67
Low:6.64
Close:6.66
Loading ...
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Apr 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Major Issues Report

Form 8-K - Current report
Dec 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Correspondence

Form CORRESP - Correspondence
Oct 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report